Novo Nordisk, United Laboratories Say New Obesity Drug Helps Patients Lose Weight in Trial

Novo Nordisk said an experimental obesity drug it is jointly developing with China’s United Laboratories International Holdings helped patients lose weight in a midstage clinical trial in China.



Source link

About The Author

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top